Overview

A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060

Status:
NOT_YET_RECRUITING

Trial end date:
2026-01-11

Target enrollment:

Participant gender:

Summary

The purpose of the study is to see and learn the effect of multiple doses of a strong CYP3A4 inhibitor and a potent UGT2B7 inhibitor on the PK of PF-07220060.

Phase:

PHASE1

Details

Lead Sponsor:

Pfizer

Treatments:

Itraconazole
Probenecid